Max F. Madu

Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2020 · 123 citations · Full text

Life Sciences, Immunology, Oncology +17

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients

Max F. Madu, Marion M. Deken, Jos A. van der Hage et al. · Annals of Surgical Oncology · 2017 · 34 citations

Medicine, Oncology, Surgery +13

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Max F. Madu, Viola Franke, Bart A. van de Wiel et al. · Melanoma Research · 2019 · 28 citations

Medicine, Clinical Sciences, Oncology +17

PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study

Max F. Madu, Pieter Timmerman, Michel W.J.M. Wouters et al. · Melanoma Research · 2017 · 19 citations

Medicine, Oncology, Radiology +17

Blue dye can be safely omitted in most sentinel node procedures for melanoma

Iris M. C. van der Ploeg, Max F. Madu, Jos A. van der Hage et al. · Melanoma Research · 2016 · 18 citations

Medicine, Oncology, Surgery +17